RUBICON ADVISORS, LLC

Lobbying for DYNAVAX TECHNOLOGIES · Pharmaceuticals

Filing 1st Quarter - Report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 23, 2026

Income

$75,000.00

What the client paid this registrant for the period.

Client based in

California

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Pharmacy

Prescription User Fee, Biomedical Advance Research and Development Authority (BARDA)

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.